Medicine and Dentistry
Prostate Specific Antigen
100%
Neurinoma
100%
NLR Family Pyrin Domain containing 3
100%
Interstitial Cystitis
100%
Cystalgia
100%
Pain
100%
Transforming Growth Factor
100%
Therapy Effect
100%
Signal Transduction
100%
Lipopolysaccharide
100%
NLRP3 Inflammasome
83%
Bladder Tissue
66%
Curcumin
66%
Chronic Inflammation
50%
Interleukin-1
50%
Conservative Treatment
33%
Bladder
33%
Bladder Injury
33%
Fibrosis
33%
Male Genital System
16%
Digital Rectal Examination
16%
Survivorship in Cancer Care
16%
Case Presentation
16%
Histopathology
16%
Patient Preference
16%
Biopsy
16%
Transrectal Ultrasonography
16%
Rare Tumor
16%
Symptom
16%
Protamine Sulfate
16%
Detrusor Muscle
16%
Interleukin 1
16%
Bladder Function
16%
Urothelium
16%
Group Therapy
16%
Sodium Chloride
16%
Urination
16%
Disease
16%
Voiding Dysfunction
16%
Vimentin
16%
Immunohistochemistry
16%
Myofibrosis
16%
down Regulation
16%
Sequela
16%
Uvomorulin
16%
Upregulation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Bladder Cancer
100%
Mitomycin
100%
Hyperthermia
100%
Chemotherapy
80%
Non Muscle Invasive Bladder Cancer
60%
Survival Rate
40%
Adverse Event
40%
Recurrence Free Survival
40%
Recurrence Risk
40%
Tumor Recurrence
20%
Therapeutic Effect
20%
Progression Free Survival
20%